Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma.

Lovestone S., Manji HK.

DOI

10.1002/cpt.1685

Type

Journal article

Publication Date

2020-01-01T00:00:00+00:00

Volume

107

Pages

79 - 81

Total pages

2

Keywords

Alzheimer Disease, Drug Development, Drug Industry, Humans, Immunologic Factors, Neuroprotective Agents, tau Proteins

Permalink More information Close